Reduced Expression Levels of Cell Surface Markers by CLL Cells With 11q Deletion
| Antigen . | P Value . | n* . | Antigen . | P Value . | n* . |
|---|---|---|---|---|---|
| Isotype control | NS | 38 | CD48 | .010 | 38 |
| CD5 | NS | 38 | CD49b | NS | 18 |
| CD6 | .014 | 30 | CD49c | NS | 30 |
| CD10 | NS | 18 | CD49d | NS | 30 |
| CD11a | .019 | 30 | CD49e | NS | 30 |
| CD11b | NS | 18 | CD49f | NS | 18 |
| CD11c | .040 | 30 | CD50 | NS | 30 |
| CD18 | .007 | 30 | CD51 | NS | 18 |
| CD20 | NS | 38 | CD54 | NS | 18 |
| CD21 | NS | 30 | CD58 | .003 | 30 |
| CD22 | NS | 18 | CD61 | NS | 18 |
| CD23 | NS | 38 | CD62L | .047† | 18 |
| CD24 | NS | 30 | CD69 | NS | 30 |
| CD26 | NS | 38 | CD70 | NS | 18 |
| CD27 | NS | 18 | CD71 | .047‡ | 18 |
| CD29 | NS | 30 | CD72 | NS | 30 |
| CD30 | NS | 18 | CD77 | NS | 18 |
| CD31 | .049 | 30 | CD79b | NS | 20 |
| CD32 | NS | 30 | CD80 | NS | 20 |
| CD35 | .012 | 30 | CD81 | NS | 30 |
| CD37 | NS | 30 | CD86 | NS | 20 |
| CD38 | NS | 30 | CD95 | NS | 18 |
| CD39 | .008 | 30 | CD102 | NS | 30 |
| CD40 | NS | 30 | CD103 | NS | 18 |
| CD40L | NS | 18 | FMC7 | NS | 20 |
| CD43 | NS | 38 | sIgM | NS | 20 |
| CD44 | NS | 30 | sIgD | NS | 20 |
| CD45 | .001 | 30 | κ | NS | 20 |
| CD46 | NS | 38 | λ | NS | 20 |
| Antigen . | P Value . | n* . | Antigen . | P Value . | n* . |
|---|---|---|---|---|---|
| Isotype control | NS | 38 | CD48 | .010 | 38 |
| CD5 | NS | 38 | CD49b | NS | 18 |
| CD6 | .014 | 30 | CD49c | NS | 30 |
| CD10 | NS | 18 | CD49d | NS | 30 |
| CD11a | .019 | 30 | CD49e | NS | 30 |
| CD11b | NS | 18 | CD49f | NS | 18 |
| CD11c | .040 | 30 | CD50 | NS | 30 |
| CD18 | .007 | 30 | CD51 | NS | 18 |
| CD20 | NS | 38 | CD54 | NS | 18 |
| CD21 | NS | 30 | CD58 | .003 | 30 |
| CD22 | NS | 18 | CD61 | NS | 18 |
| CD23 | NS | 38 | CD62L | .047† | 18 |
| CD24 | NS | 30 | CD69 | NS | 30 |
| CD26 | NS | 38 | CD70 | NS | 18 |
| CD27 | NS | 18 | CD71 | .047‡ | 18 |
| CD29 | NS | 30 | CD72 | NS | 30 |
| CD30 | NS | 18 | CD77 | NS | 18 |
| CD31 | .049 | 30 | CD79b | NS | 20 |
| CD32 | NS | 30 | CD80 | NS | 20 |
| CD35 | .012 | 30 | CD81 | NS | 30 |
| CD37 | NS | 30 | CD86 | NS | 20 |
| CD38 | NS | 30 | CD95 | NS | 18 |
| CD39 | .008 | 30 | CD102 | NS | 30 |
| CD40 | NS | 30 | CD103 | NS | 18 |
| CD40L | NS | 18 | FMC7 | NS | 20 |
| CD43 | NS | 38 | sIgM | NS | 20 |
| CD44 | NS | 30 | sIgD | NS | 20 |
| CD45 | .001 | 30 | κ | NS | 20 |
| CD46 | NS | 38 | λ | NS | 20 |
Abbreviation: NS, not significant (P ≥ .05).
Total number of cases examined. Equal numbers of B-CLL cases with/without 11q deletion were investigated.
CD62L was expressed in 1 of 9 cases with and in 3 of 9 cases without 11q deletion.
CD71 was expressed in 2 of 9 cases with and in 5 of 9 cases without 11q deletion.